Siino Valentina, Jensen Pia, James Peter, Vasto Sonya, Amato Antonella, Mulè Flavia, Accardi Giulia, Larsen Martin Røssel
Department of Immunotechnology, Lund University, Sweden.
Department of Biochemistry and Molecular Biology, PR Group, University of Southern Denmark, Odense, Denmark.
Nutr Metab Insights. 2021 May 3;14:11786388211012405. doi: 10.1177/11786388211012405. eCollection 2021.
Obesity constitutes a major global health threat and is associated with a variety of diseases ranging from metabolic and cardiovascular disease, cancer to neurodegeneration. The hallmarks of neurodegeneration include oxidative stress, proteasome impairment, mitochondrial dysfunction and accumulation of abnormal protein aggregates as well as metabolic alterations. As an example, in post-mortem brain of patients with Alzheimer's disease (AD), several studies have reported reduction of insulin, insulin-like growth factor 1 and insulin receptor and an increase in tau protein and glycogen-synthase kinase-3β compared to healthy controls suggesting an impairment of metabolism in the AD patient's brain. Given these lines of evidence, in the present study we investigated brains of mice treated with 2 obesogenic diets, high-fat diet (HFD) and high-glycaemic diet (HGD), compared to mice fed with a standard diet (SD) employing a quantitative mass spectrometry-based approach. Moreover, post-translational modified proteins (phosphorylated and N-linked glycosylated) were studied. The aim of the study was to identify proteins present in the brain that are changing their expression based on the diet given to the mice. We believed that some of these changes would highlight pathways and molecular mechanisms that could link obesity to brain impairment. The results showed in this study suggest that, together with cytoskeletal proteins, mitochondria and metabolic proteins are changing their post-translational status in brains of obese mice. Specifically, proteins involved in metabolic pathways and in mitochondrial functions are mainly downregulated in mice fed with obesogenic diets compared to SD. These changes suggest a reduced metabolism and a lower activity of mitochondria in obese mice. Some of these proteins, such as PGM1 and MCT1 have been shown to be involved in brain impairment as well. These results might shed light on the well-studied correlation between obesity and brain damage. The results presented here are in agreement with previous findings and aim to open new perspectives on the connection between diet-induced obesity and brain impairment.
肥胖是全球主要的健康威胁,与从代谢和心血管疾病、癌症到神经退行性疾病等多种疾病相关。神经退行性变的特征包括氧化应激、蛋白酶体损伤、线粒体功能障碍、异常蛋白质聚集体的积累以及代谢改变。例如,在阿尔茨海默病(AD)患者的尸检大脑中,几项研究报告称,与健康对照相比,胰岛素、胰岛素样生长因子1和胰岛素受体减少,tau蛋白和糖原合酶激酶-3β增加,这表明AD患者大脑存在代谢受损。基于这些证据,在本研究中,我们采用基于定量质谱的方法,研究了用两种致肥胖饮食(高脂饮食(HFD)和高糖饮食(HGD))处理的小鼠的大脑,并与喂食标准饮食(SD)的小鼠进行了比较。此外,还研究了翻译后修饰的蛋白质(磷酸化和N-连接糖基化)。该研究的目的是鉴定大脑中基于给予小鼠的饮食而改变其表达的蛋白质。我们认为其中一些变化将突出可能将肥胖与脑损伤联系起来的途径和分子机制。本研究结果表明,与细胞骨架蛋白一起,线粒体和代谢蛋白在肥胖小鼠大脑中的翻译后状态正在发生变化。具体而言,与标准饮食相比,喂食致肥胖饮食的小鼠中参与代谢途径和线粒体功能的蛋白质主要下调。这些变化表明肥胖小鼠的新陈代谢降低,线粒体活性降低。其中一些蛋白质,如磷酸葡萄糖变位酶1(PGM1)和单羧酸转运蛋白1(MCT1)也已被证明与脑损伤有关。这些结果可能有助于阐明肥胖与脑损伤之间已被充分研究的相关性。这里呈现的结果与先前的发现一致,旨在为饮食诱导的肥胖与脑损伤之间的联系开辟新的视角。